0001209191-22-051047.txt : 20220922 0001209191-22-051047.hdr.sgml : 20220922 20220922180047 ACCESSION NUMBER: 0001209191-22-051047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220921 FILED AS OF DATE: 20220922 DATE AS OF CHANGE: 20220922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kung Winston CENTRAL INDEX KEY: 0001666963 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40475 FILM NUMBER: 221260249 MAIL ADDRESS: STREET 1: C/O PMV PHARMACEUTICALS, INC. STREET 2: 8 CLARKE DRIVE, SUITE 3 CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Janux Therapeutics, Inc. CENTRAL INDEX KEY: 0001817713 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822289112 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10955 VISTA SORRENTO PARKWAY STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 751-4493 MAIL ADDRESS: STREET 1: 10955 VISTA SORRENTO PARKWAY STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-21 0 0001817713 Janux Therapeutics, Inc. JANX 0001666963 Kung Winston C/O JANUX THERAPEUTICS, INC. 10955 VISTA SORRENTO PARKWAY, SUITE 200 SAN DIEGO CA 92130 1 0 0 0 Stock Option (right to buy) 13.54 2022-09-21 4 A 0 30000 0.00 A 2032-09-20 Common Stock 30000 30000 D Stock Option (right to buy) 13.54 2022-09-21 4 A 0 9375 0.00 A 2032-09-20 Common Stock 9375 9375 D The shares subject to the option vest in equal monthly installments over a three year period following September 21, 2022 (the "Grant Date") such that the option is fully vested on the third anniversary of the Grant Date. The shares subject to the option vest in equal monthly installments over a one year period following September 21, 2022 (the "Grant Date") such that the option is fully vested on the first anniversary of the Grant Date. /s/ Maria Dobek, Attorney-in-Fact 2022-09-22